Drug Shortage Report for NALCROM

Last updated on 2021-05-22 History
Report ID 134957
Drug Identification Number 00500895
Brand name NALCROM
Common or Proper name Nalcrom
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) CROMOLYN SODIUM
Strength(s) 100MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100
ATC code A07EB
ATC description INTESTINALANTIINFLAMMATORY AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2021-03-31
Actual start date
Estimated end date 2021-05-21
Actual end date 2021-05-21
Shortage status Resolved
Updated date 2021-05-22
Company comments The Nalcrom shortage was due to a manufacturing delay. The extension is linked to receiving added information related to a GMP requirement. Sanofi has initiated a product allocation based on previous order history with its distributors. Availability dates at individual distributor warehouses may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-03-02 English Compare
v2 2021-03-02 English Compare
v3 2021-03-02 English Compare
v4 2021-03-02 French Compare
v5 2021-03-02 English Compare
v6 2021-03-02 French Compare
v7 2021-04-01 English Compare
v8 2021-04-23 English Compare
v9 2021-04-23 French Compare
v10 2021-04-30 English Compare
v11 2021-04-30 French Compare
v12 2021-05-21 English Compare
v13 2021-05-21 French Compare
v14 2021-05-22 English Compare